Odyssey Health (ODYY) EPS (Basic) Growth (3y) (2017 - 2026)
Odyssey Health (ODYY) EPS (Basic) Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 17.98% |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | 34.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 34.98% |
| Jan 31, 2026 | 35.40% |
| Oct 31, 2025 | 47.89% |
| Jul 31, 2025 | 43.33% |
| Apr 30, 2025 | 59.77% |
| Jan 31, 2025 | 55.49% |
| Oct 31, 2024 | 30.82% |
| Jul 31, 2024 | -68.36% |
| Apr 30, 2024 | 59.97% |
| Jan 31, 2024 | 157.26% |
| Oct 31, 2023 | 5.55% |
| Jul 31, 2023 | 18.89% |
| Apr 30, 2023 | 52.04% |
| Jan 31, 2023 | 47.61% |
| Oct 31, 2022 | 11.65% |
| Jul 31, 2022 | 66.06% |
| Apr 30, 2022 | -243.08% |
| Jan 31, 2022 | -143.80% |
| Oct 31, 2021 | -154.68% |
| Jul 31, 2021 | -219.36% |